Scienmag
Published October 15, 2026
Ketamine, Psilocybin and Brain Stimulation Offer New Hope for Treatment-Resistant OCD
Read the full story at Scienmag
At subanesthetic doses, ketamine blocks the N-methyl-D-aspartate receptor, a glutamate-gated ion channel, which triggers a downstream surge in.
Surfaced by this Google Alert
- Ketamine
